Cross Shawn's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Dec 11, 2025
- Accession no.
- 0001628280-25-056645
- Filed
- Dec 11, 2025
- Trade date
- Dec 9-10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $626.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cross ShawnCIK 0001734779 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Common Stock | MOption exerciseAcquired | +15,896 | $16.45 | +$261,489.2 | 72,146 | Direct | |
| Dec 9, 2025 | Common Stock | SSaleDisposed | −15,896 | $25.03 | −$397,876.88 | 56,250 | Direct | |
| Dec 10, 2025 | Common Stock | MOption exerciseAcquired | +9,104 | $16.45 | +$149,760.8 | 65,354 | Direct | |
| Dec 10, 2025 | Common Stock | SSaleDisposed | −9,104 | $25.14 | −$228,874.56 | 56,250 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Common Stock | MOption exerciseDisposed | −15,896 | $0.00 | $0 | 184,104 | Direct | |
| Dec 10, 2025 | Common Stock | MOption exerciseDisposed | −9,104 | $0.00 | $0 | 175,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.